Recent European supply chain due diligence laws, such as the Germany’s Act on Corporate Due Diligence Obligations in Supply Chains (LkSG) and EU’s Corporate Sustainability Due Diligence Directive, are now setting more perspective requirements for supply chain responsibility, says Pete Rau, vice president of solution consulting at EcoVadis, a provider of business sustainability ratings.
“We believe these new regulations are a good sign for levelling the playing field and raising everyone’s game and should apply to pharma companies as they would any other industry,” he says.
Read more...
About the Author
EcoVadis is a purpose-driven company whose mission is to provide the world's most trusted business sustainability ratings. Businesses of all sizes rely on EcoVadis’ expert intelligence and evidence-based ratings to manage risk and compliance, drive decarbonization, and improve the sustainability performance of their business and value chain. Its AI-powered risk mapping, actionable scorecards, benchmarks, carbon action tools, and insights guide a resilience and improvement journey for environmental, social and ethical practices across 200 industry categories and 175 countries.
Follow on Linkedin
Visit Website
More Content by EcoVadis EN